Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase".
作者信息
Yoo Jeong-Ju, Kim Sang Gyune
机构信息
Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, Korea.
出版信息
Clin Mol Hepatol. 2023 Apr;29(2):513-515. doi: 10.3350/cmh.2023.0044. Epub 2023 Feb 15.
Abstract
摘要
相似文献
1
Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase".关于“血清学免疫耐受期慢性乙型肝炎的长期预后及组织学评估需求”信件的通信
Clin Mol Hepatol. 2023 Apr;29(2):513-515. doi: 10.3350/cmh.2023.0044. Epub 2023 Feb 15.
2
Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase".关于“慢性乙型肝炎血清免疫耐受期的长期预后及组织学评估的必要性”的信函
Clin Mol Hepatol. 2023 Apr;29(2):510-512. doi: 10.3350/cmh.2023.0018. Epub 2023 Jan 30.
3
Correspondence on Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于识别慢性乙型肝炎免疫耐受期是否必不可少？”的信件往来
Clin Mol Hepatol. 2023 Jul;29(3):820. doi: 10.3350/cmh.2023.0135. Epub 2023 May 19.
4
Unresolved issues of immune tolerance in chronic hepatitis B.慢性乙型肝炎免疫耐受未解决的问题。
J Gastroenterol. 2020 Apr;55(4):383-389. doi: 10.1007/s00535-020-01665-z. Epub 2020 Feb 3.
5
A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.一项关于肝活检及乙肝表面抗原在慢性乙型肝炎感染中意义的回顾性研究
Medicine (Baltimore). 2016 Feb;95(8):e2503. doi: 10.1097/MD.0000000000002503.
6
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.慢性乙型肝炎免疫耐受期患者的HBV DNA整合与克隆性肝细胞扩增
Gastroenterology. 2016 Nov;151(5):986-998.e4. doi: 10.1053/j.gastro.2016.07.012. Epub 2016 Jul 22.
7
Histologic changes in immune-tolerant patients with chronic hepatitis B: a systematic review and meta-analysis.免疫耐受慢性乙型肝炎患者的组织学变化：系统评价和荟萃分析。
Sci Rep. 2023 Jan 10;13(1):469. doi: 10.1038/s41598-023-27545-z.
8
Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于确定慢性乙型肝炎免疫耐受期是否必不可少？”的信函
Clin Mol Hepatol. 2023 Jul;29(3):812. doi: 10.3350/cmh.2023.0132. Epub 2023 May 8.
9
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise.免疫耐受型慢性乙型肝炎的模仿者：一个伪装的杀手。
Clin Mol Hepatol. 2023 Apr;29(2):363-366. doi: 10.3350/cmh.2023.0079. Epub 2023 Mar 9.
10
Reply to: Correspondence on "Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection".回复：关于“乙肝表面抗原血清学清除对手术切除后乙肝病毒相关肝细胞癌晚期复发的影响”的通信
J Hepatol. 2022 Nov;77(5):1472-1474. doi: 10.1016/j.jhep.2022.07.032. Epub 2022 Aug 18.
本文引用的文献
1
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma.用于肝细胞癌早期检测和治疗监测的液体活检
J Liver Cancer. 2022 Sep;22(2):103-114. doi: 10.17998/jlc.2022.09.08. Epub 2022 Sep 22.
2
Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase".关于“慢性乙型肝炎血清免疫耐受期的长期预后及组织学评估的必要性”的信函
Clin Mol Hepatol. 2023 Apr;29(2):510-512. doi: 10.3350/cmh.2023.0018. Epub 2023 Jan 30.
3
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.慢性乙型肝炎血清学免疫耐受期的长期预后和组织学评估的必要性。
Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5.
4
Non-invasive tests-based risk stratification: Baveno VII and beyond.基于非侵入性检查的风险分层：巴韦诺 VII 及以后。
Clin Mol Hepatol. 2023 Jan;29(1):105-109. doi: 10.3350/cmh.2022.0361. Epub 2022 Nov 23.
5
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus.门静脉高压诊断中非侵入性工具的兴起：巴韦诺VII共识的验证
Clin Mol Hepatol. 2023 Jan;29(1):102-104. doi: 10.3350/cmh.2022.0353. Epub 2022 Nov 10.
6
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2022 Apr;28(2):276-331. doi: 10.3350/cmh.2022.0084. Epub 2022 Apr 1.
7
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.亚洲慢性乙型肝炎患者在无纤维化的情况下，即使 ALT 正常和可检测到 HBV DNA，也存在肝脏炎症。
Hepatol Commun. 2022 Apr;6(4):855-866. doi: 10.1002/hep4.1859. Epub 2021 Nov 15.
8
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels.一种用于预测血清丙氨酸氨基转移酶水平正常的慢性乙型肝炎患者肝脏炎症的非侵入性模型。
Front Med (Lausanne). 2021 Jun 4;8:688091. doi: 10.3389/fmed.2021.688091. eCollection 2021.
9
The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years.组织学炎症对1年和3年内肝脏硬度值改善的影响。
J Clin Med. 2019 Nov 24;8(12):2065. doi: 10.3390/jcm8122065.
10
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.天门冬氨酸/丙氨酸氨基转移酶的免疫学测定在预测肝纤维化和炎症中的作用。
Korean J Intern Med. 2020 Mar;35(2):320-330. doi: 10.3904/kjim.2018.214. Epub 2019 Jan 23.
Zotero 插件